EZZ Life Science Holdings Limited
EZZ Life Science Holdings Limited
Your view on EZZ.AX
Overview
What the company does, where it operates, and who runs it.
About EZZ Life Science Holdings Limited
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Mark Qin
- Headquarters
- Shop 1, 55-59 Parramatta Road, Lidcombe, NSW, AU
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Mark Qin
- Headquarters
- Shop 1, 55-59 Parramatta Road, Lidcombe, NSW, AU
EZZ Life Science Holdings Limited, an Australian company, specializes in offering a range of skincare and consumer health products, with its market presence extending across Australia, New Zealand, Mainland China, and other international territories. The company's operations are divided into two distinct segments: 'Brought in Lines' and 'Company Owned products.' EZZ is actively involved in the wholesale supply of its EAORON-branded skincare portfolio, distributing it to pharmacies, major supermarkets, specialist retailers, and general grocery stores. Furthermore, the company designs, develops, manufactures, and markets a comprehensive selection of consumer health products under its own EZZ brand. This extensive offering includes vitamins, dietary supplements, sports nutrition, weight management and wellbeing solutions, traditional herbal remedies, and paediatric lines. These EZZ-branded items are sold directly to consumers via its e-commerce platforms and various retail stores, notably Tmall Global. Founded in 2015, EZZ Life Science Holdings Limited maintains its corporate headquarters in Silverwater, Australia.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
FRC's fair value estimate for EZZ Life Science Holdings Limited, and the rating behind it. EZZ.AX last traded at AUD 0.47, 7.8× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for EZZ Life Science Holdings Limited. Starting points for EZZ Life Science Holdings Limited: P/E 7.8, EPS AUD 0.06, beta 0.91 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for EZZ Life Science Holdings Limited. EZZ Life Science Holdings Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for EZZ Life Science Holdings Limited. Trailing twelve-month EPS for EZZ Life Science Holdings Limited stands at AUD 0.06. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for EZZ Life Science Holdings Limited. EZZ Life Science Holdings Limited has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
EZZ Life Science Holdings Limited valued side by side against its closest peers. EZZ Life Science Holdings Limited is measured against Biotechnology peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
Which funds and firms own the stock.
Which institutions hold EZZ Life Science Holdings Limited, and how their positions are changing. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
Buying and selling by EZZ Life Science Holdings Limited executives and directors. Shares of EZZ Life Science Holdings Limited have traded between AUD 0.35 and AUD 3.38 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming EZZ Life Science Holdings Limited. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming EZZ Life Science Holdings Limited. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
Latest headlines and company announcements for EZZ Life Science Holdings Limited. Coverage tracks EZZ Life Science Holdings Limited within Biotechnology (Healthcare). Press releases and market coverage, newest first.